Results 51 to 60 of about 9,912 (208)
Obesity Reviews, EarlyView.ABSTRACT Introduction Weight loss results in reduced energy expenditure (EE) due to body composition alterations (e.g., fat‐free mass and fat mass losses) and mass‐independent adaptations in EE (e.g., hormones). Glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) are indicated for obesity management; however, their effects on EE remain unclear ...
Flavio T. Vieira +8 more
wiley +1 more source
PDB28 Economic Evaluation of Vildagliptin As Add-on Therapy to Metformin in Diabetes Mellitus Treatment in China [PDF]
, 2003 This repository item contains a single issue of The ISCIP Analyst, an analytical review journal published from 1996 to 2010 by the Boston University Institute for the Study of Conflict, Ideology, and ...
Adami, Fabian +8 more
core +12 more sources
Clinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1223-1234, May 2026.This review evaluates the available pharmacokinetic data on the plasma‐to‐breastmilk transfer of first‐ and second‐line T2DM drugs against available clinical guideline recommendations. A list of drug therapies for treating T2DM was generated from national and international clinical guidelines.
Katherine Richardson +4 more
wiley +1 more source
Journal of Diabetes Research, 2017 The present observational study aimed to evaluate the clinical effectiveness of vildagliptin with metformin in Korean patients with type 2 diabetes mellitus (T2DM).
Sunghwan Suh +5 more
doaj +1 more source
PDB24 Prevalence and economic burden of diabetes in africa [PDF]
, 2014 Antidiabetic activities of Phaleria macrocarpa fruits and Annona muricata leaves through α-glucosidase inhibition have been reported. Each extract of the two medicinal plants showed weak α-glucosidase inhibitory activities.
Darusman, Latifah Kosim +3 more
core +3 more sources
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.Initiation of oral semaglutide in patients with T2D in routine clinical practice in Mexico significantly reduces HbA1c and weight and improves satisfaction with treatment. ABSTRACT Background To investigate the oral semaglutide use among Mexican adults with type 2 diabetes.
Guillermo González‐Gálvez +7 more
wiley +1 more source
Pharmacoepidemiology and Drug Safety, Volume 35, Issue 5, May 2026.ABSTRACT Aim Adverse events (AEs) detected in tweets and in the FDA Adverse Event Reporting System (FAERS) provide valuable insights into patient experiences with oral hypoglycemic agents including sodium‐glucose transporter 2 (SGLT2) and dipeptidyl peptidase‐4 (DPP4) inhibitors. This study compared the side effects identified from tweets with those in
Se‐Hoon Oh +2 more
wiley +1 more source
Individualizing treatment targets for elderly patients with type 2 diabetes: factors influencing clinical decision making in the 24-week, randomized INTERVAL study. [PDF]
, 2017 ArticleThis is the final version of the article. Available from Impact Journals via the DOI in this record.We tested the feasibility of setting individualized glycemic goals and factors influencing targets set in a clinical trial in elderly patients with
Abhijit, A, Paldanius, PM, Strain, WD
core +1 more source
Diabetic Medicine, Volume 43, Issue 5, May 2026.Abstract The global prevalence of obesity and diabetes continues to rise, with metabolic‐bariatric surgery recognised as an effective intervention for obesity and type 2 diabetes, offering potential for type 2 diabetes remission and improved glycaemic control. This guideline, developed by the Joint British Diabetes Societies for Inpatient Care (JBDS‐IP)
Jeffrey W. Stephens +8 more
wiley +1 more source
Experimental and clinical pharmacology - Incretin mimetics and enhancers: mechanisms of action [PDF]
, 2008 The incretins are peptide hormones secreted from the gut in response to food. They increase the secretion of insulin. The incretin response is reduced in patients with type 2 diabetes, so drugs acting on incretins may improve glycaemic control. Incretins
Prins, Johannes B.
core +1 more source